3.6. IL-6R Neutralization with Tocilizumab Prevents Activation of the STAT3 Pathway in Pancreatic Cancer Cells Induced by Conditioned Media from hPSCs. This evidence concerns the gene STAT3 and familial pancreatic carcinoma.